Back to Search
DANIEL RYAN, MD
MD
Epilepsy Physician
NPI: 1316391949IndividualAccepts Medicare
Education
UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Class of 2016
Research & Publications (20)
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.
PMID 17075878·Cancer·2006
3-trial
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
PMID 17036355·Cancer·2006
3-trial
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors.
PMID 15073096·Clin Cancer Res·2004
3-trial
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.
PMID 14533439·Cancer Invest·2003
3-trial
Management of locally advanced adenocarcinoma of the pancreas.
PMID 12063831·Hematol Oncol Clin North Am·2002
6-review
A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors.
PMID 12490740·Oncologist·2002
3-trial
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
PMID 11815964·Cancer·2002
3-trial
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.
PMID 11234874·Clin Cancer Res·2001
3-trial
Rectal cancer: integrating oxaliplatin into chemoradiation studies.
PMID 11204662·Oncology (Williston Park)·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 501 20TH ST STE 505
KNOXVILLE, TN 37916 - Phone
- (865) 546-0157
Quick Facts
- NPI
- 1316391949
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile